Announcements Trials
Browse Landscape

Status

Unknown 2Completed 2

Sponsor Class

OTHER 3NETWORK 1

Study Type

Observational 4Interventional 4

Sponsor

Cancer Type

Breast 4

Conditions

Breast Neoplasms 31Stomach Neoplasms 4Neoplasms 4Cardiotoxicity 4Neoplasm Metastasis 3Brain Neoplasms 2Neurotoxicity Syndromes 1Neoplasms, Second Primary 1Neoplasm, Residual 1HER2-positive Breast Cancer 1HER2+ Breast Cancer 1Feasibility 1Fatigue 1Breast Cancer Organoids 1

Interventions

Echocardiography 11Electrocardiography 5Trastuzumab 4Social Determinants of Health 2Doxorubicin 2Chemoradiotherapy 2Blood Specimen Collection 2Antineoplastic Agents 2Vascular Stiffness 1Standard of Care 1Resistance Training 1Pulse Wave Analysis 1Positron Emission Tomography Computed Tomography 1Magnetic Resonance Spectroscopy 1Immunomodulating Agents 1Hematologic Tests 1Gonadal Steroid Hormones 1Exercise Test 1EGFR tyrosine kinase inhibitor 324674 1Clinical Laboratory Techniques 1Cisplatin 1Cardiography, Impedance 1Anthracyclines 1Amplified Fragment Length Polymorphism Analysis 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Observational × Cardiotoxicity × Trastuzumab × Clear all
NCT04962425 2021-07-15

Risk Assessment Model of Trastuzumab-related Cardiotoxicity in Breast Cancer Patients

Peking University Third Hospital

Unknown
240 enrolled
Breast

Breast Neoplasms, Cardiotoxicity

NCT04961307 2021-07-14

Evaluation of Heart Function in Breast Cancer Patients Using Trastuzumab

Peking University Third Hospital

Unknown
30 enrolled
Breast

Breast Neoplasms, Cardiotoxicity

NCT00875238 2018-02-19

PACE in BC

Vanderbilt University Medical Center

Completed
133 enrolled
Breast

Breast Neoplasms, Cardiotoxicity

NCT00968682 2014-12-31

CADY Study ICORG 08-01

Cancer Trials Ireland

Completed
480 enrolled
Breast

Breast Neoplasms, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡